top of page
Our Mission
The ATAD3A Patient Advocacy Alliance is committed to improving the lives of individuals affected by ATAD3A gene-related disorders, including Harel-Yoon syndrome. We support groundbreaking scientific research, provide information and a support network for patients and families, and advocate for improved medical care. Through global collaboration with researchers, clinicians, and industry leaders, we strive to accelerate discoveries, enhance treatment options, and drive meaningful change for those affected.
​
This organization is organized exclusively for charitable, educational and scientific purposes under section 501(c)(3) of the Internal Revenue Code, or corresponding section of any future federal tax code.
bottom of page
